Results 221 to 230 of about 101,789 (310)

Effect of COVID‐19 Pandemic on Epidemiology and Antimicrobial Susceptibility of Campylobacter Species, Salmonella enterica and Yersinia enterocolitica in Southwest Finland 2018–2022

APMIS, Volume 134, Issue 3, March 2026.
ABSTRACT This study investigated the effect of the COVID‐19 pandemic on the epidemiology and antimicrobial susceptibility of fecal Campylobacter spp., Salmonella enterica, and Yersinia enterocolitica strains in Southwest Finland from 2018 to 2022. Results show that the number of travel‐associated S. enterica and Campylobacter spp.
Tanja Orpana, Teemu Kallonen, Antti J. Hakanen, Marianne Gunell   +3 more
wiley   +1 more source

Clinical Profile and Outcome of Resistant Gram-Negative Infections in a Pediatric Intensive Care Unit: A Retrospective Study. [PDF]

Cureus
Shweiyat S, Banikhaled N, Haddadin YM, Alhajaj H, Alsaryrah S, Hjazeen A, Al-Khlaifat AF.   +6 more
europepmc   +1 more source

The Clinical Impact of Antibiotic Allergy Labels on One‐Year Outcomes of Solid Organ Transplant Recipients

Clinical Transplantation, Volume 40, Issue 3, March 2026.
ABSTRACT Antibiotic allergy labels (AALs) are common and often incorrect. They have many potential impacts, including the use of broader‐spectrum antibiotics and suboptimal treatment of infections. The impact of inaccurate allergy labels on post‐transplant outcomes in the solid organ transplant population is not well described.
Sashi Niranjan Nair, Paul Bigliardi, Lauren Fontana   +2 more
wiley   +1 more source

Repurposing cephalosporins as excellent anticancer agents and chemosensitizers for inflammation-driven cancer therapy. [PDF]

Sci Rep
Liu N, Cao W, Tang J, Dong R, Guo J, Luo Z, Yao Q, Teng S, Liang Z, Yang Y, Gu M, Zhou J, Chen W, Liang H, He X.   +14 more
europepmc   +1 more source

Evaluation of Drug–Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Zoliflodacin is a first‐in‐class oral spiropyrimidinetrione antibiotic being developed for patients with uncomplicated gonorrhea, including those infected with multidrug‐resistant strains. Because zoliflodacin is metabolized by cytochrome P450 3A4 (CYP3A4), concomitant administration with a CYP3A inhibitor has the potential to increase ...
Alison Luckey, Kajal B. Larson, Noha Rayad, Markus Heep, Sophie Delhomme, Gabrielle Kornmann, John P. Mueller, John P. O'Donnell, Seamus O'Brien, Rainard Fuhr, Jean‐Yves Gillon   +10 more
wiley   +1 more source

Comparative Effectiveness of Piperacillin-Tazobactam or Fluoroquinolones Versus Third-Generation Cephalosporins in Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis. [PDF]

Cureus
See JS, Wong SY.
europepmc   +1 more source

Understanding antimicrobial use by equine owners in Wales: Using cross‐sectional survey and semi‐structured interviews

Equine Veterinary Journal, Volume 58, Issue 2, Page 564-579, March 2026.
Abstract Background Antimicrobial resistance (AMR) is an increasingly serious threat to human and animal health. Antimicrobial use (AMU) in horses is gathering research interest, although there remain significant evidence gaps. Currently, there is scant qualitative research into equine owners' use of antimicrobials, specifically antibiotics, hindering ...
Rebekah B. Stuart, Fleur Miles‐Farrier, Alison M. Bard, Gwen Rees   +3 more
wiley   +1 more source

Antimicrobial resistance in <i>Bordetella pertussis</i>: A systematic review and meta-analysis. [PDF]

Epidemiol Infect
Ma K, Sun W, Pan G, Xu Y, Shi Y, Chen Y.
europepmc   +1 more source